Related Experiment Video
Updated: Apr 25, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Precordial chest pain in patients with chronic Chagas disease
Reinaldo B Bestetti1, Carolina Baraldi A Restini1
1Medical Course, University of Ribeirão Preto, Brazil. Avenida Costábile Romano, 2201, Ribeirão Preto City 14096-900, Brazil.
Insights
Precordial chest pain is common in chronic Chagas disease, often mimicking acute coronary syndrome. Microvascular angina is the likely cause, and specific medications may help manage this symptom.
Area of Science:
- Cardiology
- Infectious Diseases
- Clinical Medicine
Background:
- Precordial chest pain affects 15-33% of patients with chronic Chagas disease.
- This pain, when megaesophagus is absent, is attributed to chronic Chagas heart disease.
- Atypical features include lack of exercise association and no relief from nitroglycerin.
Purpose of the Study:
- To explore the characteristics and potential mechanisms of precordial chest pain in chronic Chagas disease.
- To investigate the differential diagnosis, particularly distinguishing it from acute coronary syndrome.
- To review potential therapeutic strategies for this symptom.
Main Methods:
- Review of previously reported cases and clinical data.
- Analysis of patient presentations and response to treatments.
- Differential diagnosis considering obstructive coronary artery disease and microvascular angina.
Main Results:
- Precordial chest pain can present atypically, sometimes resembling acute coronary syndrome.
- Microvascular angina is identified as a probable underlying mechanism, even without obstructive coronary artery disease.
- The condition may not always have a benign course and can indicate a poor prognosis.
Conclusions:
- Precordial chest pain in Chagas disease warrants careful evaluation due to its potential severity.
- Microvascular angina is a key consideration in the pathophysiology.
- Nitrates, beta-blockers, and calcium channel blockers may be beneficial treatments.
Abstract:
Precordial chest pain affects about 15% to 33% of patients with chronic Chagas disease. In the absence of megaesophagus, it should be ascribed to chronic Chagas heart disease. Precordial chest pain is atypical because it can usually neither be associated to physical exercise nor be alleviated by nitroglycerin. However, in certain circumstances, precordial chest pain can masquerade as acute coronary syndrome. Although obstructive coronary artery disease can occasionally be found, microvascular angina seems to be the mechanism behind such phenomenon. Precordial chest pain not always has a benign clinical course; sometimes, it can herald a dismal prognosis. On the basis of cases previously reported, it seems that nitrates, betablockers and/or calcium channel blockers can be of value in the treatment of this condition.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Angina III: Clinical Manifestations and Assessment
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Esophageal Achalasia
Pericarditis IV: Nursing Management

